# SOX6-MAP4K4 pathway induces autophagy and contributes to the reduced chemosensitivity of cervical cancer

## TL;DR

This study explores how the SOX6-MAP4K4 pathway causes autophagy, which may reduce cervical cancer's response to chemotherapy.

## Contribution

The paper introduces a new mechanism involving SOX6 and MAP4K4 in autophagy linked to chemoresistance in cervical cancer.

## Key findings

- SOX6 induces autophagy through the MAP4K4 pathway.
- This autophagy may reduce the effectiveness of platinum-based chemotherapy in cervical cancer.
- The findings suggest a potential target for improving chemosensitivity.

## Abstract

Some cervical cancer patients show poor response to neoadjuvant chemotherapy. Although it has been demonstrated that macroautophagy/autophagy contributes to the poor chemosensitivity, the underlying mechanism has not yet been fully clarified. In this autophagy punctum, we discuss our recent findings about the mechanism of SOX6-induced autophagy and its potential significance in the platinum-based chemotherapy of cervical cancer.